Clinical Trials Browser

Unknown × Neoplasms × anlotinib × Clear all

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT02752516 2017-09-18

A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics

Phase 1 Unknown

16 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

ANLOLA

A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics